Bruce Booth, Director at Kymera Therapeutics, Inc. (KYMR), sold 31,798 shares at $103.42 ($3.3M) on 2026-06-22, disclosed to the SEC on 2026-06-22.
Scheduled sale ($3.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.42 | 2,560 | $265K | 8.0% |
| 2 | $103.42 | 18,313 | $1.9M | 57.4% |
| 3 | $104.38 | 1,341 | $140K | 4.2% |
| 4 | $104.38 | 9,584 | $1.0M | 30.3% |
| Total | $103.75 avg | 31,798 | $3.3M | 100% |
| Filing → |
| KYMR | SELL | 2026-06-30 | $3.4M | — | Filing → |
| KYMR | SELL | 2026-06-25 | $34.8M | — | Filing → |
| KYMR | SELL | 2026-06-25 | $44.0M | — | Filing → |